Sompo Asset Management’s AbbVie ABBV Stock Holding History

Sompo Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Sell	4,960 -40	-0.8%	-$8.61K	0.2%	72
2026 Q1	$1.09M	Sell	5,000 -390	-7%	-$86.5K	0.2%	76
2025 Q4	$1.23M	Sell	5,390 -210	-4%	-$47.8K	0.21%	74
2025 Q3	$1.3M	Sell	5,600 -330	-6%	-$67.2K	0.22%	71
2025 Q2	$1.1M	Hold	5,930	–	–	0.19%	78
2025 Q1	$1.24M	Hold	5,930	–	–	0.23%	77
2024 Q4	$1.05M	Buy	5,930 +580	+11%	+$107K	0.18%	76
2024 Q3	$1.06M	Sell	5,350 -280	-5%	-$52.3K	0.17%	79
2024 Q2	$966K	Sell	5,630 -170	-3%	-$28.2K	0.16%	83
2024 Q1	$1.06M	Sell	5,800 -7,990	-58%	-$1.38M	0.17%	80
2023 Q4	$2.14M	Buy	13,790 +1,610	+13%	+$235K	0.39%	57
2023 Q3	$1.82M	Sell	12,180 -280	-2%	-$41.1K	0.4%	60
2023 Q2	$1.68M	Buy	12,460 +2,020	+19%	+$296K	0.31%	63
2023 Q1	$1.66M	Sell	10,440 -2,290	-18%	-$350K	0.35%	60
2022 Q4	$2.06M	Sell	12,730 -60	-0.5%	-$9.2K	0.47%	62
2022 Q3	$1.72M	Buy	12,790 +2,870	+29%	+$412K	0.44%	61
2022 Q2	$1.52M	Sell	9,920 -8,730	-47%	-$1.33M	0.38%	66
2022 Q1	$3.02M	Sell	18,650 -12,190	-40%	-$1.77M	0.65%	46
2021 Q4	$4.17M	Buy	30,840 +4,540	+17%	+$536K	0.83%	38
2021 Q3	$2.84M	Sell	26,300 -5,130	-16%	-$586K	0.65%	51
2021 Q2	$3.54M	Buy	31,430 +1,520	+5%	+$171K	0.72%	48
2021 Q1	$3.24M	Sell	29,910 -5,500	-16%	-$588K	0.74%	41
2020 Q4	$3.79M	Buy	35,410 +290	+0.8%	+$27.9K	0.82%	43
2020 Q3	$3.08M	Sell	35,120 -1,100	-3%	-$104K	0.74%	52
2020 Q2	$3.56M	Buy	36,220 +1,170	+3%	+$103K	0.9%	39
2020 Q1	$2.67M	Sell	35,050 -6,740	-16%	-$574K	0.71%	45
2019 Q4	$3.7M	Sell	41,790 -2,620	-6%	-$218K	0.87%	45
2019 Q3	$3.36M	Buy	+44,410	New	+$3.04M	0.84%	46
2017 Q3	–	Sell	-52,840	Closed	-$3.83M	–	92
2017 Q2	$3.83M	Sell	52,840 -15,910	-23%	-$1.07M	0.58%	68
2017 Q1	$4.48M	Sell	68,750 -2,500	-4%	-$157K	0.56%	69
2016 Q4	$4.46M	Buy	+71,250	New	+$4.35M	0.58%	68

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Sompo Asset Management's ABBV Position: Q2 2026 in Review

Sompo Asset Management reduced its AbbVie (ABBV) stake by 0.8% in Q2 2026, selling an estimated $8.61K and leaving 4,960 shares worth $1.25M. The position accounts for 0.2% of the portfolio, ranked #72.

Sompo Asset Management first reported a position in ABBV in Q4 2016 and has held it in 31 quarters since. The position peaked at $4.48M in Q1 2017. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sompo Asset Management held 4,960 shares of AbbVie worth $1.25M as of Q2 2026.
Sompo Asset Management sold 40 AbbVie shares in Q2 2026, an estimated $8.61K.
AbbVie made up 0.2% of Sompo Asset Management's portfolio in Q2 2026, its #72 holding.
Sompo Asset Management first reported a position in AbbVie in Q4 2016 and has held it in 31 quarters since.
Sompo Asset Management's AbbVie position peaked at $4.48M in Q1 2017.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sompo Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.